(Q44897131)

7 December 2017

title

Design, synthesis, and biological activity of thiazole derivatives as novel influenza neuraminidase inhibitors (English)

1 reference

7 December 2017

6

1 reference

7 December 2017

Yu Liu

1

1 reference

7 December 2017

Lei Zhang

2

1 reference

7 December 2017

Jianzhi Gong

3

1 reference

7 December 2017

Hao Fang

4

1 reference

7 December 2017

Ailin Liu

5

1 reference

7 December 2017

Wenfang Xu

7

1 reference

7 December 2017

publication date

14 December 2010

1 reference

Journal of Enzyme Inhibition and Medicinal Chemistry

7 December 2017

published in

1 reference

7 December 2017

volume

26

1 reference

7 December 2017

issue

4

1 reference

7 December 2017

page(s)

506-513

1 reference

Neuraminidase inhibitors for influenza

7 December 2017

cites work

1 reference

https://api.crossref.org/works/10.3109%2F14756366.2010.534732

Structure and functions of influenza virus neuraminidase

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F14756366.2010.534732

Evidence for a sialosyl cation transition-state complex in the reaction of sialidase from influenza virus

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F14756366.2010.534732

Recent progress in rational drug design of neuraminidase inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F14756366.2010.534732

New millennium antivirals against pandemic and epidemic influenza: the neuraminidase inhibitors.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F14756366.2010.534732

Recent strategies in the search for new anti-influenza therapies

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F14756366.2010.534732

Zanamivir and oseltamivir: two new options for the treatment and prevention of influenza

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F14756366.2010.534732

Crystal structures of oseltamivir-resistant influenza virus neuraminidase mutants

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F14756366.2010.534732

Global transmission of oseltamivir-resistant influenza

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F14756366.2010.534732

Another look at the molecular mechanism of the resistance of H5N1 influenza A virus neuraminidase (NA) to oseltamivir (OTV).

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F14756366.2010.534732

Mechanism by which mutations at his274 alter sensitivity of influenza a virus n1 neuraminidase to oseltamivir carboxylate and zanamivir

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F14756366.2010.534732

The structure of H5N1 avian influenza neuraminidase suggests new opportunities for drug design.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F14756366.2010.534732

Analogue inhibitors by modifying oseltamivir based on the crystal neuraminidase structure for treating drug-resistant H5N1 virus

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F14756366.2010.534732

On the structure-based design of novel inhibitors of H5N1 influenza A virus neuraminidase (NA).

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F14756366.2010.534732

Advances in the structure-based design of the influenza A neuraminidase inhibitors.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F14756366.2010.534732

Design, synthesis, and structural analysis of influenza neuraminidase inhibitors containing pyrrolidine cores

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F14756366.2010.534732

Recent advances in anti-influenza agents with neuraminidase as target

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F14756366.2010.534732

Three-dimensional structure of influenza A N9 neuraminidase and its complex with the inhibitor 2-deoxy 2,3-dehydro-N-acetyl neuraminic acid

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F14756366.2010.534732

BCX-1812 (RWJ-270201): discovery of a novel, highly potent, orally active, and selective influenza neuraminidase inhibitor through structure-based drug design

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F14756366.2010.534732

Design, synthesis, inhibitory activity, and SAR studies of pyrrolidine derivatives as neuraminidase inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F14756366.2010.534732

Design, synthesis, inhibitory activity, and SAR studies of hydrophobic p-aminosalicylic acid derivatives as neuraminidase inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F14756366.2010.534732

A simple and rapid liquid chromatographic assay for evaluation of potentially counterfeit Tamiflu

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F14756366.2010.534732

Comparative binding energy (COMBINE) analysis of influenza neuraminidase-inhibitor complexes.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F14756366.2010.534732

Prediction of drug binding affinities by comparative binding energy analysis.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F14756366.2010.534732

Comparison of efficacies of RWJ-270201, zanamivir, and oseltamivir against H5N1, H9N2, and other avian influenza viruses

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F14756366.2010.534732

10.3109/14756366.2010.534732

21 January 2018

Identifiers

DOI

1 reference

7 December 2017

1 reference